We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

185 hedge funds and large institutions have $860M invested in SANGAMO THERAPEUTICS INC in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 76 increasing their positions, 39 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 39

67% more call options, than puts

Call options by funds: $26.2M | Put options by funds: $15.7M

36% more capital invested

Capital invested by funds: $630M → $860M (+$230M)

4.74% more ownership

Funds ownership: 64.51% → 69.25% (+4.7%)

6% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 31

1% less funds holding

Funds holding: 187 → 185 (-2)

Holders
185
Holders Change
-2
Holders Change %
-1.07%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
76
Reduced
39
Closed
31
Calls
$26.2M
Puts
$15.7M
Net Calls
+$10.5M
Net Calls Change
+$2.07M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$71.5M
2
BG
Bellevue Group
Switzerland
+$38.8M
3
Citadel Advisors
Citadel Advisors
Florida
+$17.6M
4
BlackRock
BlackRock
New York
+$11.7M
5
N
Nuveen
North Carolina
+$8.41M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$9.23M
2
State Street
State Street
Massachusetts
-$5.37M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.96M
4
Bank of America
Bank of America
North Carolina
-$2.07M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$5.44M +$381K +35,809 +8%
DC
27
Davenport & Co
Virginia
$4.58M +$3.78M +355,876 +516%
Morgan Stanley
28
Morgan Stanley
New York
$4.56M -$1.15M -107,667 -20%
AGA
29
Altrinsic Global Advisors
Connecticut
$4.49M – – –
CS
30
Candriam SCA
Luxembourg
$4.45M +$4.41M +415,000 New
AG
31
Artal Group
Luxembourg
$4.36M +$53.2K +5,000 +1%
Macquarie Group
32
Macquarie Group
Australia
$4.31M +$3.03M +285,000 +248%
Barclays
33
Barclays
United Kingdom
$3.39M +$1.65M +154,909 +97%
Nordea Investment Management
34
Nordea Investment Management
Sweden
$3.21M -$111K -10,450 -3%
Bank of America
35
Bank of America
North Carolina
$3.19M -$2.07M -194,970 -40%
FCM
36
Frontier Capital Management
Massachusetts
$3.17M -$1.28M -120,808 -29%
SFM
37
Sphera Funds Management
Israel
$3.03M +$2.99M +281,291 New
Rafferty Asset Management
38
Rafferty Asset Management
New York
$2.83M -$246K -23,135 -8%
SGA
39
Sector Gamma AS
Norway
$2.71M +$137K +12,841 +5%
CAM
40
ClariVest Asset Management
California
$2.71M +$1.49M +140,450 +127%
PP
41
PDT Partners
New York
$2.48M +$2.45M +230,361 New
Swiss National Bank
42
Swiss National Bank
Switzerland
$2.27M +$258K +24,300 +13%
Hudson Bay Capital Management
43
Hudson Bay Capital Management
Connecticut
$2.15M +$1.81M +170,000 +567%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$2.13M -$283K -26,600 -12%
HAM
45
HHR Asset Management
New Jersey
$2.04M +$2.01M +189,360 New
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$1.91M +$217K +20,448 +13%
B
47
Bailard
California
$1.89M +$207K +19,500 +12%
PIM
48
Platinum Investment Management
Australia
$1.82M – – –
Allianz Asset Management
49
Allianz Asset Management
Germany
$1.71M -$1.29M -120,924 -43%
AllianceBernstein
50
AllianceBernstein
Tennessee
$1.67M +$125K +11,800 +8%
1
2
3 4 5

SGMO Hedge Fund Activity: Q2 2019 in Review

185 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2019, worth a combined $860M — up 36% from $630M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new SGMO positions and 31 closed out — a net gain of 2 holders — while 76 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $71.5M. The largest seller was Invesco, cutting an estimated $9.23M.

  • 185 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2019, down from 187 in Q1 2019.
  • Funds reported $860M of SANGAMO THERAPEUTICS INC stock for Q2 2019, up 36% quarter-over-quarter.
  • 33 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2019 and 31 closed out, a net change of +2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2019 was Wellington Management Group, an estimated $71.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2019 was Invesco, an estimated $9.23M sold.

Based on aggregated 13F filings for Q2 2019.